SOD1 and amyotrophic lateral sclerosis: Together, these proof-of-concept studies warrant future investigations with a larger panel of human neurons harboring different ALS-linked SOD1 mutations and a cohort of SOD1G93A mice to further assess the therapeutic potential of anti-SOD1 nanobodies for ALS.